Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Limited has announced the cessation of a total of 277,678 securities, including service and performance rights, due to unmet or unattainable conditions as of June 27, 2024. This indicates a change in the company’s capital structure, which may be of interest to investors tracking the company’s performance and stock.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
